Xcout Intel
ORYZON GENOMICS
Oryzon Genomics S.A. is a clinical-stage biopharmaceutical firm dedicated to the discovery and advancement of epigenetics-based therapies. Its primary focus is on treating cancer and central nervous system (CNS) disorders. The company's pipeline features two lead compounds in Phase II clinical trials: iadademstat (ORY-1001), a selective LSD1 inhibitor targeting oncology, and vafidemstat (ORY-2001), an LSD1 inhibitor optimized for CNS applications, addressing neurological and psychiatric conditions. Furthermore, ORY-3001, another LSD1 inhibitor, is currently in preclinical development for a range of non-cancer-related illnesses. Founded in 2000, Oryzon Genomics S.A. is headquartered in Cornellà de Llobregat, Spain.
Subscribe to see ORYZON GENOMICS’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
ORYZON GENOMICS at a glance
ORYZON GENOMICS is a biotech company headquartered in Cornellà de Llobregat, Spain. It is publicly listed (0RDB) with a market capitalisation of $261.6M. Xcout tracks 6 named people at ORYZON GENOMICS, including Carlos Buesa (President (Executive Director)).
ORYZON GENOMICS leadership
- Carlos BuesaPresident (Executive Director)
- Konstantinos AlatarisBoard Member (Independent Director)
- Luis Sánchez QuintanaBoard Member (Independent Director)
- Manuel López-FigueroaBoard Member (Independent Director)
- Montserrat VendrellBoard Member (Independent Director)
- Pierre BeaurangBoard Member (Independent Director)
Get ORYZON GENOMICS's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on ORYZON GENOMICS in Xcout Intel
- 6 named people with titles, LinkedIn and board committees
- The full competitor set, tracking, exports and API access